Cite
APA Citation
Chen, T., Chang, P. M., & Yang, M. (2021). combination of pembrolizumab and lenvatinib is a potential treatment option for heavily pretreated recurrent and metastatic head and neck cancer. Journal of the Chinese Medical Association, 84(4), 361–367. http://access.bl.uk/ark:/81055/vdc_100145478182.0x00002b